Why Choose Auburn Pharmaceutical?

  • No Contracts!
  • Hassle Free Return Policy
  • Great Savings on Short Date Items
  • Great Value on Close-out Items
  • Free Shipping (orders of $75 or more)
  • Over 3,000 AB Rated Generics
  • Fully Accredited
  • VAWD Accredited

Auburn Pharmaceutical has become one of the fastest growing generic distributors in the country. We proudly serve over 2,500 independent pharmacies, chains, hospitals and governmental agencies.

Auburn Pharmaceutical is a family-owned and operated business, established in 1993. The family has been involved in the generic pharmaceutical industry for over 45 years.

See why Auburn Pharmaceutical is "DIFFERENT" from the rest. Register and get started today!

"I have had superb experience with Auburn, especially with our rep, due to the company's general values, deals and personal ability"
Ryan from Wisconsin

"Auburn is very competitive with pricing as well as great customer service. The sales rep I have is personable and courteous"
Jay from Kentucky

"It has been a very positive, professional and enjoyable experience dealing with the company and particularly our rep, she's a delight"
Camille from Ohio

"Ordering through Auburn has always been an easy experience. The staff is friendly with no pressure to buy, but knowledgeable on specials and upcoming shortages."
Lorraine from Michigan

Study: Diabetes prevalence has doubled in past 25 years

Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research released Tuesday from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge.

read more

Wednesday April 16, 2014

Dr. Reddy's launches eszopiclone tablets

Dr. Reddy's Labs announced the launch of eszopiclone tablets (C-IV) in 1-mg, 2-mg and 3-mg form. The drug is the generic version of Lunesta (eszopiclone) tablets.

Wednesday April 16, 2014

Teva launches generic Lunesta in the U.S.

Teva Pharmaceutical Industries announced the launch of a generic equivalent to Lunesta (eszopiclone tablets) in 1-,2- and 3-mg form in the United States.

Tuesday April 15, 2014

IMS: Spending on medicines up slightly on greater utilization of healthcare system

Total spending on U.S. medicines increased 1% on a real per capita basis in 2013, while the use of healthcare services overall rose for the first time in three years, according to a new report issued today by the IMS Institute for Healthcare Informatics.

read more

Tuesday April 15, 2014